Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology

Journal of Surgical Oncology

Volumn 104, Issue 6, 2011, Pages 566-570

  Pak, Kyung Ho ^a   Yun, Mijin ^a   Cheong, Jae Ho ^a   Hyung, Woo Jin ^a   Choi, Seung Ho ^a   Noh, Sung Hoon ^a  

^a Yonsei University   (South Korea)

Author keywords

FDG PET; signet ring cell carcinoma; standard uptake values

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ANALYTIC METHOD; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOLOGY; HUMAN; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SIGNET RING CARCINOMA; STANDARDIZED UPTAKE VALUE; STOMACH CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053583997     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21997     Document Type: Article

References (27)

1. Chen J, Cheong J, Yun MJ, et al.: Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005; 103: 2383-2390. (Pubitemid 40686585)
2. Sim SH, Kim YJ, Oh DY, et al.: The role of PET/CT in detection of gastric cancer recurrence. BMC Cancer 2009; 9: 73.
3. Lim JS, Yun MJ, Kim M, et al.: CT and PET in stomach cancer: Preoperative staging and monitoring of response to therapy. Radiographics 2006; 26: 143-156. (Pubitemid 43235009)
4. Ott K, Fink U, Becker K, et al.: Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results: of a prospective trial. J Clin Oncol 2003; 21: 4604-4610. (Pubitemid 46594034)
5. Ott K, Lordick F, Herrmann K, et al.: The new credo: Induction chemotherapy in locally advanced gastric cancer: Consequences for surgical strategies. Gastric Cancer 2008; 11: 1-9. (Pubitemid 351464481)
6. Downey RJ, Akhurst T, Gonen M, et al.: Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004; 22: 3255-3260. (Pubitemid 41103680)
7. Gatenby RA, Gillies RJ,: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899. (Pubitemid 39472955)
8. Kumar R, Mavi A, Bural G, Alavi A,: Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiol Clin North Am 2005; 43: 23-33. (Pubitemid 40326557)
9. Duhaylongsod FG, Lowe VJ, Patz EF, et al.: Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995; 60: 1348-1352.
10. Vesselle H, Schmidt RA, Pugsley JM, et al.: Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000; 6: 3837-3844.
11. Pillot G, Siegel BA, Govindan R,: Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: A review. J Thorac Oncol 2006; 1: 152-159. (Pubitemid 47164003)
12. Berghmans T, Dusart M, Paesmans M, et al.: Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): A systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008; 3: 6-12.
13. Ikenaga N, Otomo N, Toyofuku A, et al.: Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors. Am Surg 2007; 73: 1151-1157. (Pubitemid 351396527)
14. Allal AS, Slosman DO, Kebdani T, et al.: Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 2004; 59: 1295-1300. (Pubitemid 38954050)
15. Lee YJ, Cho A, Cho BC, et al.: High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. Clin Cancer Res 2009; 15: 2426-2432.
16. Oyama N, Akino H, Suzuki Y, et al.: Prognostic value of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography imaging for patients with prostate cancer. Mol Imag Biol 2002; 4: 99-104. (Pubitemid 34272714)
17. van Westreenen HL, Plukker JT, Cobben DC, et al.: Prognostic value of the standardized uptake value in esophageal cancer. Am J Roentgenol 2005; 185: 436-440.
18. Vesselle H, Freeman JD, Wiens L, et al.: Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: New contrary data on prognostic role. Clin Cancer Res 2007; 13: 3255-3263. (Pubitemid 46944910)
19. Hoang JK, Hoagland LF, Coleman RE, et al.: Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma. J Clin Oncol 2008; 26: 1459-1464.
20. De Potter T, Flamen P, Van Cutsem E, et al.: Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 2002; 29: 525-529.
21. Kawamura T, Kusakabe T, Sugino T, et al.: Expression of glucose transporter-1 in human gastric carcinoma: Association with tumor aggressiveness, metastasis, and patient survival. Cancer 2001; 92: 634-641. (Pubitemid 32735200)
22. Piessen G, Messager M, Leteurtre E, et al.: Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 2009; 250: 878-887.
23. Li C, Kim S, Lai JF, et al.: Advanced gastric carcinoma with signet ring cell histology. Oncology 2007; 72: 64-68. (Pubitemid 350249131)
24. Dassen AE, Lips DJ, Hoekstra CJ, et al.: FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol 2009; 35: 449-455.
25. Japanese Gastric Cancer Association LC: Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998; 1: 10-24.
26. Hamilton SR, Aaltonen LA,: WHO classification of tumors: Pathology and genetics of tumors of the digestive system. Lyon (France): IARC press; 2000.
27. Minn H, Zasadny KR, Quint LE, et al.: Lung cancer: Reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology 1995; 196: 167-173.